|
Volumn 23, Issue 6, 2004, Pages 551-552
|
Hepatitis A in the United States
|
Author keywords
Hepatitis A; Hepatitis vaccines; Immunoglobulin
|
Indexed keywords
HEPATITIS A HEPATITIS B VACCINE;
HEPATITIS A VACCINE;
IMMUNOGLOBULIN;
CHILD;
CLINICAL FEATURE;
DRUG EFFICACY;
DRUG HYPERSENSITIVITY;
HEPATITIS A;
HEPATITIS A VIRUS;
HIGH RISK POPULATION;
HUMAN;
INCIDENCE;
INFANT;
INFECTION RISK;
NONHUMAN;
PATHOGENESIS;
PRIORITY JOURNAL;
REVIEW;
SIDE EFFECT;
UNITED STATES;
VIRUS TRANSMISSION;
ADOLESCENT;
ADULT;
AGE DISTRIBUTION;
CHILD;
CHILD, PRESCHOOL;
FEMALE;
HEPATITIS A;
HEPATITIS A VACCINES;
HUMANS;
MALE;
MIDDLE AGED;
PREVALENCE;
PROGNOSIS;
RISK ASSESSMENT;
SEX DISTRIBUTION;
UNITED STATES;
VACCINATION;
|
EID: 3042683327
PISSN: 08913668
EISSN: None
Source Type: Journal
DOI: 10.1097/01.inf.0000130071.03003.c2 Document Type: Review |
Times cited : (31)
|
References (14)
|